Taj Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 18-07-2024
- Paid Up Capital ₹ 1.05 Cr
as on 18-07-2024
- Company Age 19 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.00 Cr
as on 18-07-2024
About Taj Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.05 Cr.
The company currently has active open charges totaling ₹4.00 Cr.
Ranvir Singh, Abhishek Singh, and Sudheer Singh serve as directors at the Company.
- CIN/LLPIN
U24230MH2004PLC149424
- Company No.
149424
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
05 Nov 2004
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Taj Pharmaceuticals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ranvir Singh  | Director | 05-Nov-2004 | Current |
| Abhishek Singh | Director | 10-Mar-2009 | Current |
| Sudheer Singh | Director | 21-May-2013 | Current |
Financial Performance and Corporate Structure Insights of Taj Pharmaceuticals.
Taj Pharmaceuticals Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Taj Pharmaceuticals?
In 2023, Taj Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Taj Life Sciences Private Limited
Active
15 years 9 months Ranvir Singh and Abhishek Singh are mutual person
Sankara Nethralaya Private Limited
Active 18 years 9 months Ranvir Singh and Abhishek Singh are mutual person
Taj Institute Of Medical Sciences Private Limited
Active 20 years 2 months Ranvir Singh and Abhishek Singh are mutual person
Arcelor Chemicals Private Limited
Active 15 years 8 months Ranvir Singh and Abhishek Singh are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Indian Overseas Bank Creation Date: 13 Feb 2024 | ₹4.00 Cr | Open |
How Many Employees Work at Taj Pharmaceuticals?
Unlock and access historical data on people associated with Taj Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
As of Mar 31, 2010, Taj Pharmaceuticals has raised a total of ₹ 1.05 Cr, with the most recent deal valued at ₹ 1.05 Cr. Access detailed insights into the company’s deals, including security allotments, mergers, acquisitions, and strategic partnerships that have shaped its growth.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
